Clinical Trial Update: A Study of Docetaxel in Combination With Capecitabine in Stomach and Esophagus Cancers [Phase 2]

View source ↗

Summary

A Phase 2 trial of docetaxel in combination with capecitabine for gastric and esophageal cancers was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Gastric Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: University of Pittsburgh | Conditions: Cancer | Phase 2 | Status: TERMINATED | Results posted: 2016-02-08